WallStreetZenWallStreetZen

NASDAQ: SXTP
60 Degrees Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Be the first to know when Wall Street analysts revise their SXTP stock forecasts and price targets.

Forecast return on equity

Is SXTP forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is SXTP forecast to generate an efficient return on assets?

SXTP revenue forecast

What is SXTP's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$1.0M+298.31%
Avg 2 year Forecast
$520.0k+105.07%
Avg 3 year Forecast
$2.4M+826.75%
SXTP's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SXTP revenue growth forecast

How is SXTP forecast to perform vs Biotechnology companies and vs the US market?
Company
125.84%
Industry
61.39%
Market
9.12%
SXTP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SXTP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SXTP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SXTP$0.23N/AN/A
ONCO$0.12N/AN/A
QNRX$0.71$4.00+464.97%Strong Buy
WINT$5.07$18.00+255.38%Hold
MBIO$0.25N/AN/A
View Top Biotech Stocks

60 Degrees Pharmaceuticals Stock Forecast FAQ

What is SXTP's revenue growth forecast for 2024-2026?

(NASDAQ: SXTP) 60 Degrees Pharmaceuticals's forecast annual revenue growth rate of 125.84% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 61.39%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.12%.

60 Degrees Pharmaceuticals's revenue in 2024 is $253,573.On average, 1 Wall Street analysts forecast SXTP's revenue for 2024 to be $11,686,284, with the lowest SXTP revenue forecast at $11,686,284, and the highest SXTP revenue forecast at $11,686,284. On average, 1 Wall Street analysts forecast SXTP's revenue for 2025 to be $6,016,701, with the lowest SXTP revenue forecast at $6,016,701, and the highest SXTP revenue forecast at $6,016,701.

In 2026, SXTP is forecast to generate $27,190,858 in revenue, with the lowest revenue forecast at $27,190,858 and the highest revenue forecast at $27,190,858.

If you're new to stock investing, here's how to buy 60 Degrees Pharmaceuticals stock.

What is SXTP's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: SXTP) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 8.32%.

What is SXTP's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: SXTP) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.